Maria A. Pletneva
No Rating Available
(Learn About Our Rating System)

Maria A. Pletneva, MD, PhD

Languages spoken: English, Russian

  • Specialties

    • Pathology, Anatomical

    Board Certification

    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Hematology)

  • Board Certification and Academic Information

    Academic Departments Pathology -Associate Professor (Clinical)
    Board Certification
    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Hematology)

    Education history

    Fellowship Surgical Pathology with concentration in Gastrointestinal Pathology - University of Michigan Health System Fellow
    Fellowship Hematopathology - University of Michigan Health System Fellow
    Residency Anatomic and Clinical Pathology - University of Michigan Health System Resident
    Professional Medical Medical Scientist Training Program - Johns Hopkins University School of Medicine M.D., Ph.D.
    Undergraduate Biochemistry - University of Maryland B.S.
    Undergraduate Cellular and Molecular Biology and Genetics - University of Maryland B.S.

    Selected Publications

    Journal Article

    1. Pyne AL, Uchida AM, Hazel MW, Pletneva MA, Allen-Brady K, Peterson KA (2024). Differing Epithelial and Immunologic Activation Patterns Following Food Reintroduction Reveal Different Transcriptional Profiles in Active Eosinophilic Esophagitis. Gastroenterology. (Read full article)
    2. Pyne AL, Uchida AM, Hazel MW, Stubben CJ, Chang JW, Bailey DD, Gonsalves N, Allen-Brady K, Peterson KA, Pletneva MA (2024). Effect of benralizumab on histopathology and inflammatory signatures in a clinical cohort of eosinophilic esophagitis. Dis Esophagus. (Read full article)
    3. Kim S, Ben-Baruch Morgenstern N, Osonoi K, Aceves SS, Arva NC, Chehade M, Collins MH, Dellon ES, Falk GW, Furuta GT, Gonsalves NP, Gupta SK, Hirano I, Hiremath G, Katzka DA, Khoury P, Leung J, Pesek R, Peterson KA, Pletneva MA, Spergel JM, Wechsler JB, Yang GY, Rothenberg ME, Shoda T (2024). Nonepithelial Gene Expression Correlates With Symptom Severity in Adults With Eosinophilic Esophagitis. J Allergy Clin Immunol Pract. (Read full article)
    4. Sato H, Dellon ES, Aceves SS, Arva NC, Chehade M, Collins MH, Davis CM, Falk GW, Furuta GT, Gonsalves NP, Gupta SK, Hirano I, Hiremath G, Katzka DA, Khoury P, Leung J, Menard-Katcher P, Pesek R, Peterson KA, Pletneva MA, Spergel JM, Wechsler JB, Yang GY, Rothenberg ME, Shoda T (2024). Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis. J Allergy Clin Immunol. (Read full article)
    5. Hirano I, Dellon ES, Falk GW, Gonsalves NP, Furuta GT, Bredenoord AJ, ASCENT Working Group (2023). Ascending to New Heights for Novel Therapeutics for Eosinophilic Esophagitis. Gastroenterology. (Read full article)
    6. Genta RM, Turner KO, Collins MH, Wechsler JB, Arva NC, Pletneva MA, Dellon ES, Walker MM (2023). Quantification of Mucosal Mast Cells in the Gastrointestinal Tract: A Primer for Practicing Pathologists. Arch Pathol Lab Med. (Read full article)
    7. Boylan KE, Kanth P, Delker D, Hazel MW, Boucher KM, Affolter K, Clayton F, Evason KJ, Jedrzkiewicz J, Pletneva M, Samowitz W, Swanson E, Bronner MP (2023). Three pathologic criteria for reproducible diagnosis of colonic sessile serrated lesion versus hyperplastic polyp. Hum Pathol, 137, 25-35. (Read full article)
    8. Eisele Y, Mallea PM, Gigic B, Stephens WZ, Warby CA, Buhrke K, Lin T, Boehm J, Schrotz-King P, Hardikar S, Huang LC, Pickron TB, Scaife CL, Viskochil R, Koelsch T, Peoples AR, Pletneva MA, Bronner M, Schneider M, Ulrich AB, Swanson EA, Toriola AT, Shibata D, Li CI, Siegel EM, Figueiredo J, Janssen KP, Hauner H, Round J, Ulrich CM, Holowatyj AN, Ose J (2021). Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study. Clin Colorectal Cancer, 20(3), e165-e172. (Read full article)

    Review

    1. Collins MH, Arva NC, Bernieh A, Lopez-Nunez O, Pletneva M, Yang GY (2024). Histopathology of Eosinophilic Esophagitis. [Review]. Immunol Allergy Clin North Am, 44(2), 205-221. (Read full article)
    2. Arva NC, Bernieh A, Lopez-Nunez O, Pletneva M, Yang GY, Collins MH (2024). Histopathology of Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis. [Review]. Immunol Allergy Clin North Am, 44(2), 369-381. (Read full article)

    Letter

    1. Talley NJ, Peterson KA, Genta RM, Chang AT, Dellon ES, Sandborn WJ, 019 Study Team, Lacy BE, Chehade M, Hirano I, Gonsalves N, Lembo A, Schmitt CM, Rothenberg ME, Jain N, Pletneva MA, Turner KO, Youngblood BA (2022). High Discovery Rate of Duodenal and Gastric Eosinophilia in Patients With Unexplained Moderate-Severe Abdominal Symptoms: A Prospective US Multisite Study. [Letter to the editor]. Gastroenterology, 164(4), 680-683.e2. (Read full article)
    2. Arva N, Genta RM, Pletneva M, Walker MM, Yang GY, Collins MH (2022). Eosinophilic Gastrointestinal Disorders: A new Path. [Letter to the editor]. Pediatr Dev Pathol, 25(5), 568-569. (Read full article)